Synedgen, Inc., Corporation just released form D about $3.50 million debt financing. This is a new filing. Synedgen was able to sell $3.00 million. That is 85.71% of the financing round. The total private offering amount was $3.50 million. The private financing document was filed on 2016-11-07. The reason for the financing was: unspecified. The fundraising still has about $500,000 more and is not closed yet. We have to wait more to see if the offering will be fully taken.
Synedgen is based in California. The company’s business is Pharmaceuticals. The form was signed by Shenda Baker President. The company was incorporated more than five years ago. The filler’s address is: 1420 N. Claremont Boulevard, Suite 105D, Claremont, Ca, California, 91711. Shenda Baker is the related person in the form and it has address: C/O Synedgen, Inc., 1420 N. Claremont Boulevard, Suite 105D, Claremont, Ca, California, 91711. Link to Synedgen Filing: 000147161816000004.
Analysis of Synedgen Offering
On average, firms in the Pharmaceuticals sector, sell 60.90% of the total offering amount. Synedgen sold 85.71% of the offering. The financing is still open. Could this mean that the trust in Synedgen is high? The average financing size for companies in the Pharmaceuticals industry is $556,000. The total amount raised is 439.57% bigger than the average for companies in the Pharmaceuticals sector. The minimum investment for this financing is set at $0. If you know more about the reasons for the financing, please comment below.
What is Form D? What It Is Used For
Form D disclosures could be used to track and understand better your competitors. The information in Form D is usually highly confidential for ventures and startups and they don’t like revealing it. This is because it reveals amount raised or planned to be raised as well as reasons for the financing. This could help competitors. Entrepreneurs usually want to keep their financing a ‘secret’ so they can stay in stealth mode for longer.
Why Fundraising Reporting Is Good For Synedgen Also
The Form D signed by Shenda Baker might help Synedgen, Inc.’s sector. First, it helps potential customers feel more safe to deal with a firm that is well financed. The odds are higher that it will stay in the business. Second, this could attract other investors such as venture-capital firms, funds and angels. Third, positive PR effects could even bring leasing firms and venture lenders.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.